Herzzentrum Lahr
About Herzzentrum Lahr
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
CVRx, Inc.
2
Pfizer
2
Cogentus Pharmaceuticals
1
Daiichi Sankyo, Inc.
1
Deutsches Herzzentrum Muenchen
1
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
1
Clinical Trials at Herzzentrum Lahr
During the past decade, Herzzentrum Lahr conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Safety and Efficacy of Six Months Dual Antiplatelet Therapy After Drug-Eluting Stenting
2008-09-01
2014-11-01
Unknown status
4,005
Coronary Artery Disease and Renal Failure Registry
2007-12-01
2013-05-01
Unknown status
3,352
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
2016-12-13
2024-07-01
Recruiting
500
Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
2017-03-21
2021-02-28
Completed
1,426
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Herzzentrum Lahr" #1 sponsor was "CVRx, Inc." with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Deutsches Herzzentrum Muenchen"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Lahr"
#1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Herzzentrum Lahr
According to Clinical.Site data, the most researched conditions in "Herzzentrum Lahr" are
"Coronary Artery Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Herzzentrum Lahr" in a lesser frequency.
Clinical Trials Intervention Types at Herzzentrum Lahr
Most popular intervention types in "Herzzentrum Lahr" are "Drug" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "BAROSTIM NEO™ System" (1 trials), "Barostim Neo™ System" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Herzzentrum Lahr
The vast majority of trials in "Herzzentrum Lahr" are
8 trials for "All" genders.
Clinical Trials Status at Herzzentrum Lahr
Currently, there are NaN active trials in "Herzzentrum Lahr".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Herzzentrum Lahr,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Herzzentrum Lahr, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".